These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33009006)

  • 1. Impaired neurocognitive function in glioma patients: from pathophysiology to novel intervention strategies.
    Noll KR; Walbert T; Wefel JS
    Curr Opin Neurol; 2020 Dec; 33(6):716-722. PubMed ID: 33009006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative Neurocognitive Function in Glioma Surgery.
    Noll KR; Bradshaw M; Sheppard D; Wefel JS
    Curr Oncol Rep; 2024 May; 26(5):466-476. PubMed ID: 38573439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in Functional Connectomics Associated With Neurocognitive Changes Following Glioma Resection.
    Noll KR; Chen HS; Wefel JS; Kumar VA; Hou P; Ferguson SD; Rao G; Johnson JM; Schomer DF; Suki D; Prabhu SS; Liu HL
    Neurosurgery; 2021 Feb; 88(3):544-551. PubMed ID: 33080024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.
    Wefel JS; Noll KR; Rao G; Cahill DP
    Neuro Oncol; 2016 Dec; 18(12):1656-1663. PubMed ID: 27576872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma.
    Noll KR; Bradshaw ME; Weinberg JS; Wefel JS
    Psychooncology; 2017 May; 26(5):617-624. PubMed ID: 26677053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive functioning in patients with glioma of the left and right temporal lobes.
    Noll KR; Ziu M; Weinberg JS; Wefel JS
    J Neurooncol; 2016 Jun; 128(2):323-31. PubMed ID: 27022915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection.
    Noll KR; Sullaway C; Ziu M; Weinberg JS; Wefel JS
    Neuro Oncol; 2015 Apr; 17(4):580-7. PubMed ID: 25227126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials.
    Caramanna I; Bottomley A; Drijver AJ; Twisk J; van den Bent M; Idbaih A; Wick W; Pe M; Klein M; Reijneveld JC;
    Eur J Cancer; 2021 Feb; 144():162-168. PubMed ID: 33348088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between tumor location and neurocognitive functioning using tumor localization maps.
    Habets EJJ; Hendriks EJ; Taphoorn MJB; Douw L; Zwinderman AH; Vandertop WP; Barkhof F; De Witt Hamer PC; Klein M
    J Neurooncol; 2019 Sep; 144(3):573-582. PubMed ID: 31410731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe Glioma.
    Noll KR; Weinberg JS; Ziu M; Benveniste RJ; Suki D; Wefel JS
    Neurosurgery; 2015 Nov; 77(5):777-85. PubMed ID: 26317672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.
    van Kessel E; Baumfalk AE; van Zandvoort MJE; Robe PA; Snijders TJ
    J Neurooncol; 2017 Aug; 134(1):9-18. PubMed ID: 28567586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of neurocognitive function in association with WHO grades in gliomas.
    Yamawaki R; Nankaku M; Umaba C; Ueda M; Liang N; Mineharu Y; Yamao Y; Ikeguchi R; Matsuda S; Miyamoto S; Arakawa Y
    Clin Neurol Neurosurg; 2021 Sep; 208():106824. PubMed ID: 34329808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study.
    van Kessel E; Snijders TJ; Baumfalk AE; Ruis C; van Baarsen KM; Broekman ML; van Zandvoort MJE; Robe PA
    J Neurooncol; 2020 Jan; 146(1):97-109. PubMed ID: 31802314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a retrospective cohort study prior to antitumor treatment.
    van Kessel E; Emons MAC; Wajer IH; van Baarsen KM; Broekman ML; Robe PA; Snijders TJ; Van Zandvoort MJE
    Neurooncol Pract; 2019 Dec; 6(6):463-472. PubMed ID: 31832216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients.
    Wefel JS; Zhou R; Sulman EP; Boehling NS; Armstrong GN; Tsavachidis S; Liang FW; Etzel CJ; Kahalley LS; Small BJ; Scheurer ME; Bondy ML; Liu Y
    J Neurooncol; 2022 Jan; 156(1):185-193. PubMed ID: 34817796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive Function in Newly Diagnosed Low-grade Glioma Patients Undergoing Surgical Resection With Awake Mapping Techniques.
    Racine CA; Li J; Molinaro AM; Butowski N; Berger MS
    Neurosurgery; 2015 Sep; 77(3):371-9; discussion 379. PubMed ID: 25930064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials.
    Caramanna I; Reijneveld JC; van de Ven PM; van den Bent M; Idbaih A; Wick W; Taphoorn MJB; Dirven L; Bottomley A; Klein M;
    Eur J Cancer; 2023 Jun; 186():38-51. PubMed ID: 37028200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of low-grade gliomas: a review of patient-perceived quality of life and neurocognitive outcome.
    Shields LB; Choucair AK
    World Neurosurg; 2014; 82(1-2):e299-309. PubMed ID: 24560709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour and surgery effects on cognitive functioning in high-grade glioma patients.
    Habets EJ; Kloet A; Walchenbach R; Vecht CJ; Klein M; Taphoorn MJ
    Acta Neurochir (Wien); 2014 Aug; 156(8):1451-9. PubMed ID: 24879620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function.
    Li J; Bentzen SM; Renschler M; Mehta MP
    J Clin Oncol; 2007 Apr; 25(10):1260-6. PubMed ID: 17401015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.